Diagnostic value of fractional exhaled nitric oxide in differentiating the Asthma-COPD overlap from COPD: a systematic review and meta-analysis

ConclusionFeNO as an inflammatory biomarker is effective in differentiating ACO from COPD and assisting in clinical decision-making.PMID:34821171 | DOI:10.1080/17476348.2022.2011221

Source: Expert Review of Respiratory Medicine - November 25, 2021 Category: Respiratory Medicine Authors: Chuchu Zhang Meng Zhang Yalei Wang Xiaojie Su Ting Lei Haichuan Yu Jian Liu Source Type: research